These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 28887115

  • 1. Blau Syndrome-Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series.
    Sarens IL, Casteels I, Anton J, Bader-Meunier B, Brissaud P, Chédeville G, Cimaz R, Dick AD, Espada G, Fernandez-Martin J, Guly CM, Hachulla E, Harjacek M, Khubchandani R, Mackensen F, Merino R, Modesto C, Naranjo A, Oliveira-Knupp S, Özen S, Pajot C, Ramanan AV, Russo R, Susic G, Thatayatikom A, Thomée C, Vastert S, Bertin J, Arostegui JI, Rose CD, Wouters CH.
    Am J Ophthalmol; 2018 Mar; 187():158-166. PubMed ID: 28887115
    [Abstract] [Full Text] [Related]

  • 2. Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome).
    Carreño E, Guly CM, Chilov M, Hinchcliffe A, Arostegui JI, Lee RW, Dick AD, Ramanan AV.
    Acta Ophthalmol; 2015 May; 93(3):253-7. PubMed ID: 25209167
    [Abstract] [Full Text] [Related]

  • 3. Long-Term Visual Outcome of Patients with Blau Syndrome.
    Kreps EO, Al Julandani D, Guly CM, Arostegui JI, Dick AD, Ramanan AV.
    Ocul Immunol Inflamm; 2024 Oct; 32(8):1728-1732. PubMed ID: 38180755
    [Abstract] [Full Text] [Related]

  • 4. Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis.
    Bansal R, Gupta A, Gupta V, Dogra MR, Sharma A, Bambery P.
    Ophthalmology; 2012 Nov; 119(11):2334-42. PubMed ID: 22892153
    [Abstract] [Full Text] [Related]

  • 5. Blau-Jabs Syndrome in a Tertiary Ophthalmologic Center.
    Nascimento H, Sousa JM, Fernández DG, Salomão GHA, Sato EH, Muccioli C, Belfort R.
    Ophthalmic Surg Lasers Imaging Retina; 2018 Jan 01; 49(1):70-75. PubMed ID: 29304271
    [Abstract] [Full Text] [Related]

  • 6. Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene.
    Raiji VR, Miller MM, Jung LK.
    J AAPOS; 2011 Apr 01; 15(2):205-7. PubMed ID: 21596301
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lipogranulomatous subconjunctival nodules: a novel presentation in Blau syndrome.
    Ahmad M, Hermanson ME, Enzenauer R, Palestine A, Lin C, Meeks N, McCourt E.
    J AAPOS; 2017 Jun 01; 21(3):249-251. PubMed ID: 28532706
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical features of uveitis in children and adolescents at a tertiary referral centre in Tokyo.
    Keino H, Watanabe T, Taki W, Nakayama M, Nakamura T, Yan K, Okada AA.
    Br J Ophthalmol; 2017 Apr 01; 101(4):406-410. PubMed ID: 27335142
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM, Dosari M, Hemachandran S, Gikandi PW, Al-Muammar A.
    Acta Ophthalmol; 2017 Feb 01; 95(1):85-90. PubMed ID: 27535102
    [Abstract] [Full Text] [Related]

  • 17. Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization.
    Mansour AM, Arevalo JF, Fardeau C, Hrisomalos EN, Chan WM, Lai TY, Ziemssen F, Ness T, Sibai AM, Mackensen F, Wolf A, Hrisomalos N, Heiligenhaus A, Spital G, Jo Y, Gomi F, Ikuno Y, Akesbi J, LeHoang P, Adan A, Mahendradas P, Khairallah M, Guthoff R, Ghandour B, Küçükerdönmez C, Kurup SK.
    Can J Ophthalmol; 2012 Jun 01; 47(3):269-74. PubMed ID: 22687305
    [Abstract] [Full Text] [Related]

  • 18. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
    Díaz-Llopis M, Salom D, Garcia-de-Vicuña C, Cordero-Coma M, Ortega G, Ortego N, Suarez-de-Figueroa M, Rio-Pardo MJ, Fernandez-Cid C, Fonollosa A, Blanco R, Garcia-Aparicio AM, Benitez-Del-Castillo JM, Olea JL, Arevalo JF.
    Ophthalmology; 2012 Aug 01; 119(8):1575-81. PubMed ID: 22525047
    [Abstract] [Full Text] [Related]

  • 19. Uveitis in sporadic Blau syndrome: Long-term follow-up of a refractory case treated successfully with adalimumab.
    Naik AU, Annamalai R, Biswas J.
    Indian J Ophthalmol; 2018 Oct 01; 66(10):1483-1485. PubMed ID: 30249847
    [Abstract] [Full Text] [Related]

  • 20. Ocular signs predictive of tubercular uveitis.
    Gupta A, Bansal R, Gupta V, Sharma A, Bambery P.
    Am J Ophthalmol; 2010 Apr 01; 149(4):562-70. PubMed ID: 20149341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.